Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome
- PMID: 31144478
- PMCID: PMC6625365
- DOI: 10.1002/mgg3.741
Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome
Abstract
Background: Alport Syndrome (AS) is a progressive hereditary glomerular disease. It is often accompanied by sensorineural hearing loss and ocular abnormalities and can sometimes develop into end stage renal disease (ESRD), which is caused by mutations in the genes encoding the collagen type IV family of proteins.
Methods: This study analyzed the association between the clinical data of seven AS families and genes and the disease progression of different mutation types, including COL4A3 (OMIM 120070),COL4A4 (OMIM 120131), and COL4A5 (OMIM303630).
Results: A total of six new pathogenic mutation sites, one complex heterozygous mutation at COL4A3, and a combined mutation of COL4A5 and INF2 (OMIM 610982) were identified in this study. It was revealed that the clinical manifestations of X-linked AS caused by mutations in the COL4A5 gene were more severe in males than in females. In addition, the difference in patient phenotype can be attributed to the location of gene mutations affecting the protein domain or functional domain. Our data suggested that the gene deletion and nonsense mutations had a high risk for progression to ESRD.
Conclusion: Our results revealed the spectrum of type IV collagen genes, which contribute to the enrichment of database resources and has important implications in the diagnosis, prognosis, and guiding treatment of AS.
Keywords: Alport Syndrome; Genotype-phenotype correlation; prognostic impact.
© 2019 Chinese PLA General Hospital, Department of Nephrology. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures



Similar articles
-
Alport syndrome. Molecular genetic aspects.Dan Med Bull. 2009 Aug;56(3):105-52. Dan Med Bull. 2009. PMID: 19728970
-
Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.Mol Genet Genomic Med. 2019 May;7(5):e647. doi: 10.1002/mgg3.647. Epub 2019 Mar 18. Mol Genet Genomic Med. 2019. PMID: 30883042 Free PMC article.
-
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.PLoS One. 2016 Sep 14;11(9):e0161802. doi: 10.1371/journal.pone.0161802. eCollection 2016. PLoS One. 2016. PMID: 27627812 Free PMC article.
-
Novel Mutations of COL4A5 Identified in Chinese Families with X-Linked Alport Syndrome and Literature Review.Biomed Res Int. 2021 Mar 2;2021:6664973. doi: 10.1155/2021/6664973. eCollection 2021. Biomed Res Int. 2021. PMID: 33748275 Free PMC article. Review.
-
Familial hematuria: A review.Medicina (Kaunas). 2017;53(1):1-10. doi: 10.1016/j.medici.2017.01.002. Epub 2017 Jan 31. Medicina (Kaunas). 2017. PMID: 28236514 Review.
Cited by
-
The heterozygous mutation COL4A4 c.817-1G>A causes Alport syndrome in a Chinese family: a case report.Front Pediatr. 2025 May 8;13:1533638. doi: 10.3389/fped.2025.1533638. eCollection 2025. Front Pediatr. 2025. PMID: 40406358 Free PMC article.
-
Identification of COL4A4 variants in Chinese patients with familial hematuria.Front Genet. 2023 Jan 9;13:1064491. doi: 10.3389/fgene.2022.1064491. eCollection 2022. Front Genet. 2023. PMID: 36699462 Free PMC article.
-
Spectrum of Alport syndrome in an Indian cohort.Pediatr Nephrol. 2025 Feb;40(2):393-405. doi: 10.1007/s00467-024-06507-1. Epub 2024 Sep 16. Pediatr Nephrol. 2025. PMID: 39278986
-
Novel method for the genomic analysis of PKD1 mutation in autosomal dominant polycystic kidney disease.Front Cell Dev Biol. 2023 Jan 9;10:937580. doi: 10.3389/fcell.2022.937580. eCollection 2022. Front Cell Dev Biol. 2023. PMID: 36699011 Free PMC article.
-
Formins in Human Disease.Cells. 2021 Sep 27;10(10):2554. doi: 10.3390/cells10102554. Cells. 2021. PMID: 34685534 Free PMC article. Review.
References
-
- Boyer, O. , Benoit, G. , Gribouval, O. , Nevo, F. , Tete, M. J. , Dantal, J. , … Antignac, C. (2011). Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. Journal of the American Society of Nephrology, 22(2), 239–245. 10.1681/asn.2010050518 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials